Back

International Journal of Cancer

18 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Assessing the risk of early-onset dementia within 5 years of cancer diagnosis
2026-02-15 epidemiology 10.64898/2026.02.12.26346204
#1 (13.4%)
Show abstract

ObjectiveTo evaluate risk of early-onset dementia (EOD) after diagnosis of cancer among Medicaid beneficiaries. DesignLongitudinal observational study of Medicaid enrollment, inpatient, and outpatient claims data from 26 states and Washington, DC, 2001-2019. MethodsBeneficiaries aged 18-64 with [≥]6 months of enrollment were matched 1:1 on cancer status (lung, colon, breast, prostate) by age, sex, race, year and state. We estimated the weighted cumulative incidence functions of EOD at 1, 2,...

2
Application of Mendelian randomization to appraise causality in relationships between the gut microbiome and cancer
2026-01-05 epidemiology 10.64898/2026.01.05.26343428
#1 (6.3%)
Show abstract

Cancer is among the leading causes of death worldwide; however, with incidence rising, there is a requirement to identify novel risk factors and biomarkers to prevent and diagnose cancer earlier. Previous work has implicated a role of the gut microbiome in cancer aetiology; however, its causal relevance is not clear. Whilst Mendelian randomisation (MR) is increasingly being applied to assess the causal role of the gut microbiome on several health outcomes, the complexities and limitations of the...

3
Joint modelling of PSA dynamics and prostate cancer risks: A population-based study
2026-02-22 epidemiology 10.64898/2026.02.15.26346131
Top 0.1% (5.7%)
Show abstract

While the prostate-specific antigen (PSA) test is a widely used prostate cancer screening tool, its application remains controversial. Opportunistic PSA testing generates complex data in which testing intensities, PSA levels, and prostate cancer diagnosis are interdependent. Conventional analyses rarely model these processes jointly. The objective of this study was to develop a population-based joint model to analyse PSA dynamics, retesting patterns, and prostate cancer risk. We used the Stockho...

4
Differences in utilization, complications, and mortality after cancer surgery by HIV status among Medicaid beneficiaries from 2001-2021
2026-02-14 epidemiology 10.64898/2026.02.12.26346189
Top 0.1% (5.7%)
Show abstract

BackgroundPeople with HIV (PWH) experience higher cancer-specific mortality and may have worse surgical outcomes than people without HIV (PWoH), though the limited prior evidence largely predates the treat-all antiretroviral therapy (ART) era. We examined postoperative outcomes among PWH and PWoH enrolled in Medicaid in 26 states and Washington, D.C. from 2001-2021. MethodsWe identified the first inpatient/outpatient surgery for anal, bladder, breast, colorectal, female genitourinary, gastroeso...

5
Association Between Clostridioides difficile Test Positivity and Incident Colorectal Cancer in a Multisite Hospital-Based Retrospective Cohort Analysis
2026-02-24 epidemiology 10.64898/2026.02.19.26346648
Top 0.2% (5.1%)
Show abstract

IntroductionSporadic colorectal cancer (CRC) remains a significant driver of worldwide morbidity and mortality. Environmental factors associated with CRC are increasingly well-described and now include generalized colonic dysbiosis and individual enteric bacteria. Clostridioides difficile is one such species, with recent mouse model work suggesting prolonged exposure to C. difficile toxin B is conducive to colonic tumorigenesis. However, there is a dearth of real-world human evidence linking C. ...

6
Early Population-Level Impact of Helicobacter pylori Eradication on Gastric Cancer Deaths in Japan: A Counterfactual Analysis of Short-Term Divergence
2026-02-26 epidemiology 10.64898/2026.02.24.26346975
Top 0.2% (4.8%)
Show abstract

BackgroundHelicobacter pylori infection accounts for 98% of gastric cancer (GC) cases in Japan. Since 2013, the nationwide expansion of H. pylori eradication therapy to chronic gastritis patients has created a unique opportunity to evaluate its population-level impact on GC primary prevention. However, short-term reductions in GC deaths are difficult to interpret given the long natural history of gastric carcinogenesis. This study aimed to assess the early impact of population-level eradication ...

7
Risk-Benefit Balance of Habitual Ultraviolet Exposure for Cardiovascular, Cancer, and Skin Cancer Mortality: A UK Biobank Cohort Study
2026-01-15 epidemiology 10.64898/2026.01.08.26343592
Top 0.2% (4.8%)
Show abstract

ObjectiveTo examine how habitual ultraviolet (UV) exposure relates to cause-specific mortality and incidence, to quantify trade-offs between non-skin disease and skin cancer, and to explore potential circulating mediators. DesignA population-based prospective cohort study with epidemiological and proteomic mediation analyses. SettingUK Biobank, recruited from 22 assessment centres across England, Scotland, and Wales. Participants419 007 adults of White European ancestry with data on habitual ...

8
Digestive system cancer mortality trends by age and sex in Peru, 2001-2020, and projections to 2030
2025-12-20 epidemiology 10.64898/2025.12.17.25342534
Top 0.3% (3.9%)
Show abstract

BackgroundDigestive system cancer is a leading cause of mortality worldwide. This study aimed to identify changes in digestive system cancer mortality in Peru (2001-2020) by age and sex, and to predict trends through 2030. MethodsDeath records for digestive system cancers (anus, colon, esophagus, stomach, liver and intrahepatic bile ducts, small intestine, pancreas, rectum, biliary tract, and gallbladder) in Peru were analyzed from the World Health Organization mortality database for 2001-2020....

9
The impact of patient ethnicity on cancer incidence following platelet count and C-reactive protein tests in English primary care: a cohort study of 5 million patients
2026-03-04 primary care research 10.64898/2026.03.03.26347503
Top 0.3% (3.9%)
Show abstract

BackgroundPlatelet count and C-reactive protein (CRP) are blood tests commonly used in primary care as part of diagnostic work up for symptomatic patients. Abnormal results of these tests can indicate an undetected cancer; however, it is not known whether the association between an abnormal test result and cancer risk varies by patient ethnicity. MethodsThis cohort study used routinely collected primary and secondary health care records in England with linkage to national cancer registry data. ...

10
Evaluating the impact of age on prostate cancer overdiagnosis using long-term follow-up from a randomised trial
2026-01-28 epidemiology 10.64898/2026.01.26.26344830
Top 0.3% (3.9%)
Show abstract

Prostate cancer overdiagnosis is detection of prostate cancer through PSA testing that otherwise would not have been diagnosed within the patients lifetime. It is a major concern to policymakers due to its impact on quality of life. We used long-term followup data from the CAP randomised trial of a one-off screen, and English male competing mortality rates (2021-23), to estimate the impact of age on excess prostate cancer incidence within 15 years ( overdiagnosis) using competing risks methods. ...

11
Early Life-Course Patterns Of Registry-Defined Subsequent Cancers After HPV-Related Malignancies In A U.S. Population-Based Cohort
2026-01-16 epidemiology 10.64898/2026.01.14.26344109
Top 0.3% (3.8%)
Show abstract

BackgroundSubsequent primary malignancies following human papillomavirus (HPV)-related cancers represent an important survivorship concern. However, evidence remains limited regarding sociodemographic and clinical factors associated with registry-defined subsequent cancers among children, adolescents, and young adults in U.S. population-based cohorts. MethodsWe conducted a retrospective population-based analysis of 1,326 individuals diagnosed with HPV-related cancers using Surveillance, Epidemi...

12
Model-Based Evaluation of Colorectal Cancer Screening Effectiveness: Three Rounds of Multitarget Stool DNA Testing Versus One Colonoscopy
2026-02-02 gastroenterology 10.64898/2026.01.30.26344467
Top 0.3% (3.7%)
Show abstract

BackgroundSeveral colorectal cancer (CRC) screening modalities are guideline-recommended in the United States, yet they vary considerably in screening interval and real-world adherence. As a result, single-round test performance may not reflect cumulative effectiveness over time. This study compared the 10-year longitudinal outcomes of two CRC screening strategies-- triennial next-generation multitarget stool DNA testing (ng mt-sDNA) and decennial screening colonoscopy. MethodsThis study used t...

13
Effectiveness of new treatment modalities for localized prostate cancer through patient-reported outcome measures: 5 years comparative study.
2026-03-05 epidemiology 10.64898/2026.03.04.26347624
Top 0.3% (3.6%)
Show abstract

BackgroundNo randomized clinical trial comparing the most established new modalities of treatment for patients with localized prostate cancer has been published, and there is scarce comparative effectiveness research assessing Patient-Reported Outcome Measures (PROMs). Objectiveto compare the impact of active surveillance, robot-assisted radical prostatectomy (RARP), Intensity-modulated radiotherapy (IMRT), and real-time brachytherapy on patients, through PROMs, from pre-treatment to five years...

14
Survival Analysis on Papillary Thyroid Cancer Through Cox Proportional Hazards Model
2025-12-30 oncology 10.64898/2025.12.23.25342949
Top 0.4% (2.0%)
Show abstract

Cancer accounts for one in six deaths globally, making patient survivorship critical for medical professionals. Thyroid cancer incidence is rising in the United States, with Papillary Thyroid Cancer (PTC) representing approximately 80% of cases. This study develops a semi-parametric Cox Proportional Hazards model to investigate associations between PTC patient survival time and five risk factors: age, sex, malignant tumor size, race, and cancer stage. Our final Cox-PH model, which satisfies all ...

15
Understanding Bladder Cancer Screening Limits Through Comparative Modeling: The Maximum Clinical Incidence Reduction (MCLIR) Methodology
2026-01-30 oncology 10.64898/2026.01.27.26344939
Top 0.4% (2.0%)
Show abstract

BackgroundBladder cancer imposes substantial clinical and economic burden, yet key natural-history quantities that determine the potential effectiveness of screening--such as the size of the screen-detectable preclinical reservoir and the preclinical sojourn time--are largely unobservable. The Cancer Intervention and Surveillance Modeling Network (CISNET) uses standardized stress tests to compare independently developed microsimulation models and to clarify how differences in model structure tra...

16
Prostate cancer risk prediction using polygenic hazard scores in Nordic populations
2026-01-08 oncology 10.64898/2026.01.07.26343583
Top 0.5% (1.9%)
Show abstract

Context SummaryO_ST_ABSKey ObjectiveC_ST_ABSCan polygenic hazard scores accurately predict prostate cancer disease risk and age at diagnosis in Nordic populations? Knowledge GeneratedPolygenic hazard score PHS601 stratified prostate cancer risk with a towfold increase per standard deviation increase in two Norwegian populations (N = 17,538). The top 1.7% of scores conferred 8.7-fold higher risk compared with median risk, exceeding the risk associated with pathogenic HOXB13 variants. PURPOSEMor...

17
Within-Group Racial and Ethnic Differences in County-Level Socio-Behavioral Risk Across Cancer Mortality Tertiles in the United States
2026-02-26 oncology 10.64898/2026.02.24.26347030
Top 0.5% (1.9%)
Show abstract

ImportancePersistent racial and ethnic disparities in breast and prostate cancer mortality are well documented. Most prior studies emphasize between-group differences and rely on population averages or single composite measures of social disadvantage, which can obscure high-need communities within groups. How socio-behavioral determinants of health vary within groups across local gradients of cancer mortality remains incompletely characterized. A framework that combines race- and cancer-specific...

18
Prognostic and Therapeutic Relevance of BRCA1/2 Zygosity in Prostate Cancer: A Multicohort Desk-Based Analysis
2026-02-16 oncology 10.64898/2026.02.13.26346266
Top 0.5% (1.9%)
Show abstract

IntroductionBRCA1/2 alterations are increasingly recognized as biologically and clinically relevant features in prostate cancer, yet the prognostic and therapeutic significance of zygosity status remains uncertain. Understanding differences between monoallelic and biallelic inactivation may refine risk stratification and guide therapeutic decision-making. Materials and MethodsA retrospective, desk-based observational analysis was performed using publicly accessible datasets from TCGA-PRAD (prim...

19
Association of Y-chromosomal gr/gr deletions with testicular germ cell tumor: whole-genome analysis of 198,306 individuals
2026-02-05 oncology 10.64898/2026.02.04.26345360
Top 0.5% (1.9%)
Show abstract

PurposeGermline deletions affecting the Y-chromosomal gr/gr region were reported in 2005 as associated with susceptibility to testicular germ cell tumor (TGCT), a highly heritable tumor type that is the most common cancer type affecting adult men under the age of 45. Attempts to replicate this association have been equivocal, primarily due to limited power. MethodsHere, we compare and validate two computational approaches to gr/gr deletion calling in high-, low- and ultra-low-coverage whole gen...

20
Identification of circulating lipidomic biomarkers of malnutrition risk among oncology patients in the Total Cancer Care (TCC) Study: a Cross-Sectional Analysis
2026-01-11 epidemiology 10.64898/2026.01.09.26343797
Top 0.6% (1.9%)
Show abstract

BackgroundEarly identification of malnutrition is critical for improving clinical outcomes in oncology patients. However, there are no established biomarkers for malnutrition screening. ObjectiveThis study aimed to identify circulating lipid species associated with malnutrition risk among oncology patients through lipidomic analysis. MethodsA cross-sectional study was conducted using plasma samples from oncology patients classified as at risk (n = 90) or not at risk (n = 90) for malnutrition u...